Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 139Breast Neoplasms 31Prostatic Neoplasms 29Insulin Resistance 28Obesity 19Pancreatic Neoplasms 13Infertility 12Endometrial Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Colorectal Neoplasms 11Anovulation 9Lung Neoplasms 8Metabolic Syndrome 7Melanoma 7Hyperandrogenism 7Glioblastoma 7Diabetes Mellitus 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Rectal Neoplasms 5Adenocarcinoma 5Weight Loss 4Urinary Bladder Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Carcinoma, Ovarian Epithelial 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Recurrence 3

Interventions

Gemcitabine 11Albumin-Bound Paclitaxel 7Taxes 5130-nm albumin-bound paclitaxel 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3Fluorouracil 3dehydroftorafur 2Oxaliplatin 2Losartan 2Leucovorin 2Irinotecan 2Cisplatin 2niraparib 1irinotecan sucrosofate 1folfirinox 1durvalumab 1X-Rays 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1S 1 (combination) 1Resistance Training 1Radiotherapy, Image-Guided 1Radiosurgery 1Radiation 1Panitumumab 1Pancreaticoduodenectomy 1Optical Imaging 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Adenocarcinoma × Metformin × Clear all
NCT02336087 2026-02-04

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

City of Hope Medical Center

Phase 1 Active not recruiting
21 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡